Association of a NOS1 promoter repeat with Alzheimer's disease

Neurobiology of Aging - Tập 29 - Trang 1359-1365 - 2008
Daniela Galimberti1, Elio Scarpini1, Eliana Venturelli1, Alexander Strobel2, Sabine Herterich3, Chiara Fenoglio1, Ilaria Guidi1, Diego Scalabrini1, Francesca Cortini1, Nereo Bresolin1, Klaus-Peter Lesch4, Andreas Reif4
1Department of Neurological Sciences, “Dino Ferrari” Center, University of Milan, Fondazione Ospedale Maggiore Policlinico IRCCS, Milan, Italy
2Department of Psychology II, Dresden University of Technology, Dresden, Germany
3Central Laboratory, Department of Clinical Biochemistry and Pathobiochemistry, University of Würzburg, Würzburg, Germany
4Department of Psychiatry and Psychotherapy, Section of Clinical and Molecular Psychobiology, University of Würzburg, Würzburg, Germany

Tài liệu tham khảo

Akiyama, 2000, Inflammation and Alzheimer's disease, Neurobiol. Aging, 21, 383, 10.1016/S0197-4580(00)00124-X Akomolafe, 2006, Genetic association between endothelial nitric oxide synthase and Alzheimer disease, Clin. Genet., 70, 49, 10.1111/j.1399-0004.2006.00638.x Bros, 2006, Transcription of human neuronal nitric oxide synthase mRNAs derived from different first exons is partly controlled by exon 1-specific promoter sequences, Genomics, 87, 463, 10.1016/j.ygeno.2005.11.013 Colton, 2002, APOE and the regulation of microglial nitric oxide production: A link between genetic risk and oxidative stress, Neurobiol. Aging, 23, 777, 10.1016/S0197-4580(02)00016-7 Colton, 2004, APOE genotype-specific differences in human and mouse macrophage nitric oxide production, J. Neuroimmunol., 147, 62, 10.1016/j.jneuroim.2003.10.015 Corder, 1993, Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families, Science, 261, 921, 10.1126/science.8346443 Crawford, 2000, No association between the NOS3 codon 298 polymorphism and Alzheimer's disease in a sample from the United States, Ann. Neurol., 47, 687, 10.1002/1531-8249(200005)47:5<687::AID-ANA30>3.0.CO;2-4 Dahiyat, 1999, Association between Alzheimer's disease and the NOS3 gene, Ann. Neurol., 46, 664, 10.1002/1531-8249(199910)46:4<664::AID-ANA18>3.0.CO;2-J Del Bo, 1997, The apolipoprotein E ɛ4 allele causes a faster decline of cognitive performances in Down's syndrome subjects, J. Neurol. Sci., 145, 87, 10.1016/S0022-510X(96)00249-3 Dinerman, 1994, Endothelial nitric oxide synthase localized to hippocampal pyramidal cells: implications for synaptic plasticity, Proc. Natl. Acad. Sci. U.S.A., 91, 4214, 10.1073/pnas.91.10.4214 Galimberti, 2005, Association of neuronal nitric oxide synthase C276T polymorphism with Alzheimer's disease, J. Neurol., 252, 985, 10.1007/s00415-005-0783-2 Guidi, 2005, Influence of the Glu298Asp polymorphism of NOS3 on age at onset and homocysteine levels in AD patients, Neurobiol. Aging, 26, 789, 10.1016/j.neurobiolaging.2004.07.003 Hensley, 1998, Electrochemical analysis of protein nitrotyrosine and dityrosine in the Alzheimer brain indicates region-specific accumulation, J. Neurosci., 18, 8126, 10.1523/JNEUROSCI.18-20-08126.1998 Higuchi, 2000, NOS3 polymorphism not associated with Alzheimer's disease in Japanese, Ann. Neurol., 48, 685, 10.1002/1531-8249(200010)48:4<685::AID-ANA20>3.0.CO;2-L Hyman, 1992, Relative sparing of nitric oxide synthase-containing neurons in the hippocampal formation in Alzheimer's disease, Ann. Neurol., 32, 818, 10.1002/ana.410320618 Law, 2001, Say NO to Alzheimer's disease: the putative links between nitric oxide and dementia of the Alzheimer's type, Brain Res. Brain Res. Rev., 35, 73, 10.1016/S0165-0173(00)00051-5 Liang, 2006, Covariate analysis of late-onset Alzheimer disease refines the chromosome 12 locus, Mol. Psychiatry, 11, 280, 10.1038/sj.mp.4001766 Liou, 2002, No association between the neuronal nitric oxide synthase gene polymorphism and Alzheimer's disease, Am. J. Med. Gen., 114, 687, 10.1002/ajmg.10670 Luth, 2002, Aberrant expression of NOS isoforms in Alzheimer's disease is structurally related to nitrotyrosine formation, Brain Res., 953, 135, 10.1016/S0006-8993(02)03280-8 McKhann, 1984, Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease, Neurology, 34, 939, 10.1212/WNL.34.7.939 Monastero, 2003, No association between Glu298Asp endothelial nitric oxide synthase polymorphism and Italian sporadic Alzheimer's disease, Neurosci. Lett., 341, 229, 10.1016/S0304-3940(03)00210-6 Moreno-Lopez, 2000, Morphological bases for a role of nitric oxide in adult neurogenesis, Brain Res., 869, 244, 10.1016/S0006-8993(00)02474-4 Nathan, 2005, Protection from Alzheimer's-like disease in the mouse by genetic ablation of inducible nitric oxide synthase, J. Exp. Med., 202, 1163, 10.1084/jem.20051529 Porrello, 2006, Estrogen receptor α and ApoEɛ4 polymorphisms interact to increase risk for sporadic AD in Italian females, Eur. J. Neurol., 13, 639, 10.1111/j.1468-1331.2006.01333.x Reif, 2004, Differential effect of endothelial nitric oxide synthase (NOS-III) on the regulation of adult neurogenesis and behaviour, Eur. J. Neurosci., 20, 885, 10.1111/j.1460-9568.2004.03559.x Reif, 2006, A neuronal nitric oxide synthase (NOS-I) haplotype associated with schizophrenia modifies prefrontal cortex function, Mol. Psychiatry, 11, 286, 10.1038/sj.mp.4001779 Rupniak, 2000, Oxidative neuropathology and putative chemical entities for Alzheimer's disease: neuroprotective effects of salen-manganese catalytic anti-oxidants, Neurotoxicol. Res., 2, 167, 10.1007/BF03033792 Sánchez-Guerra, 2001, The Glu298Asp polymorphism in the NOS3 gene is not associated with sporadic Alzheimer's disease, J. Neurol. Neurosurg. Psychiatry, 70, 566, 10.1136/jnnp.70.4.566 Saur, 2002, Complex regulation of human neuronal nitric oxide synthase exon 1c gene transcription, J. Biol. Chem., 277, 25798, 10.1074/jbc.M109802200 Saur, 2004, Single-nucleotide promoter polymorphism alters transcription of neuronal nitric oxide synthase exon 1c in infantile hypertrophic pyloric stenosis, Proc. Natl. Acad. Sci. U.S.A., 101, 1662, 10.1073/pnas.0305473101 Šimić, 2000, nNOS expression in reactive astrocytes correlates with increased cell death related DNA damage in the hippocampus and entorhinal cortex in Alzheimer's disease, Exp. Neurol., 165, 12, 10.1006/exnr.2000.7448 Singleton, 2001, Nitric oxide synthase gene polymorphisms in Alzheimer's disease and dementia with Lewy bodies, Neurosci. Lett., 303, 33, 10.1016/S0304-3940(01)01694-9 Sundar, 2006, Gender-specific association of ATP-binding cassette transporter 1 (ABCA1) polymorphisms with the risk of late-onset Alzheimer's disease., Neurobiol Aging Tedde, 2002, Lack of association between NOS3 polymorphism and Italian sporadic and familial Alzheimer's disease, J. Neurol., 249, 110, 10.1007/PL00007839 The Italian Longitudinal Study on Aging, 1997, Prevalence of chronic diseases in older Italians: comparing self-reported and clinical diagnosis, Int. J. Epidemiol., 26, 995, 10.1093/ije/26.5.995 Thorns, 1998, nNOS expressing neurons in the entorhinal cortex and hippocampus are affected in patients with Alzheimer's disease, Exp. Neurol., 15, 14, 10.1006/exnr.1997.6751 Wang, 1999, RNA diversity has profound effects on the translation of neuronal nitric oxide synthase, Proc. Natl. Acad. Sci. U.S.A., 96, 12150, 10.1073/pnas.96.21.12150 Xu, 1996, Human apolipoprotein E2, E3, and E4 isoform-specific transgenic mice: human-like pattern of glial and neuronal immunoreactivity in central nervous system not observed in wild-type mice, Neurobiol. Dis., 3, 229, 10.1006/nbdi.1996.0023 Zhang, 2004, Multiple variable first exons: a mechanism for cell- and tissue-specific gene regulation, Genome Res., 14, 78, 10.1101/gr.1225204